Abstract:Cardiovascular diseases (CVDs) are complex, multifactorial conditions that require personalized assessment and treatment. Advancements in multi-omics technologies, namely RNA sequencing and whole-genome sequencing, have provided translational researchers with a comprehensive view of the human genome. The efficient synthesis and analysis of this data through integrated approach that characterizes genetic variants alongside expression patterns linked to emerging phenotypes, can reveal novel biomarkers and enable the segmentation of patient populations based on personalized risk factors. In this study, we present a cutting-edge methodology rooted in the integration of traditional bioinformatics, classical statistics, and multimodal machine learning techniques. Our approach has the potential to uncover the intricate mechanisms underlying CVD, enabling patient-specific risk and response profiling. We sourced transcriptomic expression data and single nucleotide polymorphisms (SNPs) from both CVD patients and healthy controls. By integrating these multi-omics datasets with clinical demographic information, we generated patient-specific profiles. Utilizing a robust feature selection approach, we identified a signature of 27 transcriptomic features and SNPs that are effective predictors of CVD. Differential expression analysis, combined with minimum redundancy maximum relevance feature selection, highlighted biomarkers that explain the disease phenotype. This approach prioritizes both biological relevance and efficiency in machine learning. We employed Combination Annotation Dependent Depletion scores and allele frequencies to identify variants with pathogenic characteristics in CVD patients. Classification models trained on this signature demonstrated high-accuracy predictions for CVD. The best performing of these models was an XGBoost classifier optimized via Bayesian hyperparameter tuning, which was able to correctly classify all patients in our test dataset. Using SHapley Additive exPlanations, we created risk assessments for patients, offering further contextualization of these predictions in a clinical setting. Across the cohort, RPL36AP37 and HBA1 were scored as the most important biomarkers for predicting CVDs. A comprehensive literature review revealed that a substantial portion of the diagnostic biomarkers identified have previously been associated with CVD. The framework we propose in this study is unbiased and generalizable to other diseases and disorders.

Connections for Matters of the Heart: Network Medicine in Cardiovascular Diseases

Multi-omics approaches for revealing the complexity of cardiovascular disease

Big data, artificial intelligence, and cardiovascular precision medicine

Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases

Network Medicine in the Age of Biomedical Big Data

Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential

Present Researching Approaches and Future Prospects forTreatment of Cardiac Diseases - Integrative Medicine

Integrative network analysis interweaves the missing links in cardiomyopathy diseasome

Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology

Computational Biology in the Discovery of Biomarkers in the Diagnosis, Treatment and Management of Cardiovascular Diseases

Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine

Connected Health Technology for Cardiovascular Disease Prevention and Management

Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases

Metabolomics: Implication in cardiovascular research and diseases

Recent Advancement in Nanotechnology based Drug Delivery for the Management of Cardiovascular disease.

A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies

Transcriptomic and Multi-scale Network Analyses Reveal Key Drivers of Cardiovascular Disease

Recent Progress in Cardiovascular Research Involving Single-Cell Omics Approaches

Heart-brain axis: Pushing the boundaries of cardiovascular molecular imaging

Use of Multi-Modal Data and Machine Learning to Improve Cardiovascular Disease Care

Single-cell spatial transcriptomics in cardiovascular development, disease, and medicine